234 BATH ROAD, SLOUGH, BERKSHIRE, X0
Material disclosure
Announces $175 Million Accelerated Share Repurchase
Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
Annual Report to Security Holders
Indivior Pharmaceuticals Issues $500 Million Convertible Senior Notes
Other Events
Announces Proposed Convertible Senior Notes Offering
Reports Fourth Quarter and Full-Year 2025 Financial Results
Q1
FY 2024
Q3
Q2
Annual and Transition Report of Foreign Private Issuers
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
Certificate
Amended Direct Registration System
Definitive Proxy Statement
Additional Proxy Materials
Definitive Additional Information Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS